SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18423985
Source:
http://linkedlifedata.com/resource/pubmed/id/18423985
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036341
,
umls-concept:C0087111
,
umls-concept:C0871261
,
umls-concept:C1276996
,
umls-concept:C1527178
,
umls-concept:C1704632
,
umls-concept:C1705938
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
1-3
pubmed:dateCreated
2008-6-24
pubmed:abstractText
To test whether early onset of response to antipsychotic medications accurately predicts subsequent response in the treatment of patients with schizophrenia.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8804207
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/olanzapine
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0920-9964
pubmed:author
pubmed-author:Ascher-SvanumHayaH
,
pubmed-author:ChenLeiL
,
pubmed-author:KaneJohn MJM
,
pubmed-author:KinonBruce JBJ
,
pubmed-author:Kollack-WalkerSaraS
,
pubmed-author:SniadeckiJennifer LJL
,
pubmed-author:StaufferVirginia LVL
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-40
pubmed:dateRevised
2010-9-2
pubmed:meshHeading
pubmed-meshheading:18423985-Adult
,
pubmed-meshheading:18423985-Antipsychotic Agents
,
pubmed-meshheading:18423985-Benzodiazepines
,
pubmed-meshheading:18423985-Double-Blind Method
,
pubmed-meshheading:18423985-Drug Administration Schedule
,
pubmed-meshheading:18423985-Drug Resistance
,
pubmed-meshheading:18423985-Female
,
pubmed-meshheading:18423985-Humans
,
pubmed-meshheading:18423985-Male
,
pubmed-meshheading:18423985-Predictive Value of Tests
,
pubmed-meshheading:18423985-Probability
,
pubmed-meshheading:18423985-Psychiatric Status Rating Scales
,
pubmed-meshheading:18423985-Psychometrics
,
pubmed-meshheading:18423985-Randomized Controlled Trials as Topic
,
pubmed-meshheading:18423985-Schizophrenia
,
pubmed-meshheading:18423985-Schizophrenic Psychology
,
pubmed-meshheading:18423985-Sensitivity and Specificity
,
pubmed-meshheading:18423985-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia.
pubmed:affiliation
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Kinon_Bruce@Lilly.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't